Clinical Trial for Pancreatic Cancer


Vol. 9, No. 3
December, 1999

  • External Beam Radiation Therapy Makes a Quantum Leap

  • Ambulatory Surgery Unit Expands

  • New Island Hospital Breaks Ground

  • Winthrop is Y2K Ready

  • Indigo Laser Relieves Symptoms of Benign Prostate Hyperplasia

  • Rheumatoid Arthritis Study

  • Dr. Scott Named Heart Association President

  • New Interventional Radiology Suite Unveiled

  • Mammotome® Breast Biopsy Procedure

  • Drug May Help Prevent Lung and Brain Damage in Premature Babies

  • Winthrop Nurses Never Stop Learning

  • Clinical Trial for Pancreatic Cancer

  • Winthrop: A Center for Lifesaving Autologous Stem Cell Transplants

  • Carnival in Venice Benefits Winthrop

  • John Broder Named Businessperson of the Year

  • Yuletide Ball

  • Winthrop’s Ninth Annual Flu Immunization Program Reached 1,500 Senior Citizens

  • Teens for Tots/Teen Angels’ Donation to Child Life Program

  • Winthrop’s Deserving Volunteers Receive Awards

  • Volunteers Needed at Winthrop

  • Visiting Scholar from Taiwan Studies at Winthrop

  • For Long Island Children who don't have Health Insurance

  • Copyright

    Back to Publications

  • Novel clinical treatments for pancreatic cancer are now available to medically eligible patients at Winthrop in a Phase II clinical study. Winthrop is one of only seven sites, nationally, to offer an immunotherapy protocol for pancreatic cancer, based on an innovative technique.

    Patients with inoperable pancreatic cancer, both locally advanced and metastatic, may be eligible for the trial of this new, first line therapy. The treatment involves removing the patient’s lymphocytes, or immune-effector cells, and activating them, in the laboratory environment, with the immune cells of a healthy individual. The new mixture, or cytoimplant, is then injected into the patient’s primary tumor. The goal is to stimulate a reaction against the primary tumor and its metastatic sites.

    Frank Gress, MD, Director of the Endoscopic Ultrasound Center for Diagnostic and Therapeutic Intervention, Division of Gastroenterology, Hepatology, and Nutrition, and Jeffrey G. Schneider, MD, Faculty Attending, Division of Oncology/Hematology, are the clinical co-investigators. For further information, call Diane Redmond, CCRA, Data Coordinator, Division of Oncology-Hematology, at (516) 663-4611.



    [ Home | Search | Contact | Directions | Privacy Notice ]

    Winthrop-University Hospital | 259 First Street | Mineola NY 11501 | 516-663-0333

    This site provides information as a resource. It is not a substitute for professional medical advice.
    Always consult a physician or healthcare provider for treatment and guidance toward good health.
    Copyright © 2008 Winthrop-University Hospital. All rights reserved. Long Island Web Design